Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Radio Frequency ID Could Be Implemented On At Least Limited Scale By 2007, Group Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Results from a pilot study released by the “Jumpstart” anti-counterfeit coalition indicate that RFID technology could satisfy regulatory and retailer requirements. Pfizer says global standards need to be developed before widespread adoption will occur.

You may also be interested in...



Economics Of Electronic Rx Anti-Counterfeit Technology Are Favorable – HDMA Report

The financial return from adopting electronic product codes that use radio frequency identification to address Rx supply chain integrity issues would exceed the costs, a Healthcare Distribution Management Association report finds

Economics Of Electronic Rx Anti-Counterfeit Technology Are Favorable – HDMA Report

The financial return from adopting electronic product codes that use radio frequency identification to address Rx supply chain integrity issues would exceed the costs, a Healthcare Distribution Management Association report finds

Pfizer Expands Color-Shifting Labels Beyond Viagra To Celebrex, Lipitor

Pfizer is expanding its use of color-shifting labels beyond Viagra to five other products as part of its anti-counterfeiting efforts.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS057799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel